Because of the January Effect, the time to research and buy stocks that may be poised to benefit from potential seasonal ...
In contrast to AbbVie, Pfizer ( PFE 2.29%) stands out as more of a turnaround opportunity, offering investors the chance to ...
That translates to growth of almost 6%, fueled by ... due to lower average selling prices. Despite the raised guidance and several analyst price target increases, SKX stock has not moved much ...
What has Wall Street been buzzing about this week? Here are the top 5 Buy calls and the top 5 Sell calls made by Wall Street’s best analysts ...